Ventilating the Bearded: A Randomized Crossover Trial Comparing a Novel Bag-Valve-Guedel Adaptor to a Standard Mask.


Journal

Military medicine
ISSN: 1930-613X
Titre abrégé: Mil Med
Pays: England
ID NLM: 2984771R

Informations de publication

Date de publication:
14 08 2020
Historique:
received: 01 04 2019
revised: 08 09 2019
accepted: 10 09 2019
entrez: 14 1 2021
pubmed: 15 1 2021
medline: 4 3 2021
Statut: ppublish

Résumé

Emergency field ventilation using bag-valve face mask devices can be difficult to perform, especially in bearded individuals. In view of the increasing numbers of servicemen and civilians sporting a beard or moustache, the issue of finding a technical solution for ventilation in this population has gained importance. We therefore developed a novel adaptor that enables the direct connection of a bag-valve device to a Guedel-type oropharyngeal airway device thereby directly connecting the oral airway to the bag valve, eliminating the need for a face mask. The objective of this study was to compare the efficacy of the bag-valve-Guedel adaptor (BVGA) to the common face mask in healthy bearded volunteers. This study was a randomized-by-sequence, crossover-controlled trial (NCT02768246) approved by the local IRB (0051-16-HMO). All subjects signed an informed consent before participation. Twenty-five healthy bearded men (age 28 ± 7) were recruited. After randomization, the first group (mask then BVGA, n = 12) began breathing room air through the face mask, followed by 100% O2. After washout in room air, the procedure was repeated with the BVGA. The second group (BVGA then mask, n = 13) began with the BVGA followed by the face mask. Subjects were awake and breathed spontaneously throughout the experiment. Therefore, a Guedel was not used. Physiological and respiratory parameters were monitored continuously. The primary endpoint was the presence of suspected leak as determined by end-tidal-CO2 (EtCO2 < 20 mmHg). Secondary endpoints included tidal volume and safety. The order of device use did not affect the results significantly (p > 0.05 by Mann-Whitney-U test); therefore, the data were pooled. There were no cases of suspected leak while breathing through the BVGA. By contrast, while breathing through a face mask, there were 8 of 25 (32%) and 5 of 25 (20%) cases of suspected leak in air and 100% O2, respectively (air: p = 0.002; 100% O2: p = 0.014 by McNemar test). No adverse events were observed. In bearded individuals, the BVGA provides significantly more efficient (less leak) ventilation compared to a face mask. This is also of particular importance in view of the increasing number of bearded individuals serving in the armed forces. Moreover, since effective ventilation with a mask requires experience, the relatively easy-to-apply BVGA will enable less experienced first responders to achieve higher success rates in this critical phase of treatment. Further studies are planned to evaluate the efficacy of the BVGA in the prehospital setting.

Identifiants

pubmed: 33444455
pii: 5614297
doi: 10.1093/milmed/usz378
doi:

Banques de données

ClinicalTrials.gov
['NCT02768246']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1300-e1308

Informations de copyright

© Association of Military Surgeons of the United States 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Lilach Gavish (L)

Institute for Research in Military Medicine (IRMM) of the Faculty of Medicine, The Hebrew University of Jerusalem, Israel and the Israel Defense Forces Medical Corps, Israel.
Institute for Medical Research (IMRIC), Faculty of Medicine, The Hebrew University of Jerusalem, Israel.

Mor Rittblat (M)

Institute for Research in Military Medicine (IRMM) of the Faculty of Medicine, The Hebrew University of Jerusalem, Israel and the Israel Defense Forces Medical Corps, Israel.

S David Gertz (SD)

Institute for Research in Military Medicine (IRMM) of the Faculty of Medicine, The Hebrew University of Jerusalem, Israel and the Israel Defense Forces Medical Corps, Israel.
Institute for Medical Research (IMRIC), Faculty of Medicine, The Hebrew University of Jerusalem, Israel.

Ruth Shaylor (R)

Department of Anesthesiology and Critical Care Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
The Department of Anaesthesia, Pain and Intensive Care, Sourasky Medical Center, Tel Aviv, Israel.

Charles Weissman (C)

Department of Anesthesiology and Critical Care Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

Arik Eisenkraft (A)

Institute for Research in Military Medicine (IRMM) of the Faculty of Medicine, The Hebrew University of Jerusalem, Israel and the Israel Defense Forces Medical Corps, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH